Janone technologies announces closing of registered direct offering priced at-the-market under nasdaq rules

Las vegas, aug. 22, 2023 /prnewswire/ -- janone (nasdaq: jan) (the "company"), a biopharmaceutical company specializing in developing non-addicting pain killers and treatments for underlying causes of pain, today announced that it has closed its previously announced registered direct offering for the purchase and sale of 899,348 shares of the company's common stock (or prefunded warrants in lieu thereof) at a purchase price of $0.8811 per share of common stock (or prefunded warrant) in a registered direct offering priced at-the-market under nasdaq rules. in addition, in a concurrent private placement, the company issued unregistered warrants to purchase 899,348 shares of common stock at an exercise price of $0.7561 per share.
JAN Ratings Summary
JAN Quant Ranking